Stillbirth Summit 2017 –

November 13, 2017
Print Friendly, PDF & Email

The 2017 Stillbirth Summit was once again a great success.  We are extremely grateful to all of the researchers from all around the world who came together to share their work and the health professionals and families who joined them.  As the videos are edited we will make them available.  The full agenda with links to the videos as they become available can be found here.

This video is the presentation entitled  The Association Between the 39-week Rule and USA Term Stillbirth Rates: An Update and a Discussion of Ethical Implications –by James Nicholson, MD

Dr. James A. Nicholson obtained his undergraduate degree from Earlham College in 1977, his medical degree from the University of Pennsylvania in 1981, and completed his internship and residency with the Duke-Watts Family Medicine Residency Program in Durham, North Carolina in 1984.

Following his residency, Dr. Nicholson joined a private practice in North Grosvenordale, Connecticut. In 1997, Dr. Nicholson returned to the University of Pennsylvania to join the Department of Family Practice and Community Medicine. While pursuing a Master’s Degree in Clinical Epidemiology, he published the AMOR-IPAT system of identifying pregnant women who would benefit from induction before 40 weeks of gestation. The publication was an editor’s choice paper in the American Journal of Obstetrics and Gynecology. The AMOR-IPAT concept was further developed and followed-up with a prospective, randomized clinical trial (RCT) of AMOR-IPAT (the HUP-POP Trial). In 2012, Dr. Nicholson moved to the Hershey Medical Center of Penn State University in the Department of Family Medicine and Community Medicine, the Department of Obstetrics and Gynecology and the Department of Pediatrics.

In the last few years Dr. Nicholson has become increasingly concerned about the rising numbers of stillbirths in the US and has studied the correlation between the ’39 week rule’ implementation and the rate of stillbirth. He is speaking to multiple organizations and institutions regarding his concerns about the 39-week rule implementation. His data was presented at the Annual Meeting of the Society for Maternal Fetal Medicine in Feb 2016.

Add your first comment to this post

Share via
Copy link